/TLX

TLX

Updated 10 July 08:16 am

$16.33

TELIX PHARMACEUTICALS LIMITED

1D-3.60%
1M+21.29%
1Y-32.94%
Health Care · Pharmaceuticals, Biotechnology & Life Sciences

Track your position in TLX

Sign in to TradeLedgr to record trades in TLX (TELIX PHARMACEUTICALS LIMITED) with parcel-level precision and ATO-compliant reporting.

Recent Announcements

Appendix 3H (Notification of cessation of securities)
Appendix 3G
Appendix 2A
08 Jul 2026 7:49 AM
2394KB
Change in substantial holding
Change in substantial holding
03 Jul 2026 3:36 AM
191KB
Ceasing to be a substantial holder
Ceasing to be a substantial holder

Fundamentals

P/E Ratio

-99999.99x

Div Yield

0.00%

EPS

$-0.0296

Avg Vol

2.7M

52W High

$27.400

52W Low

$8.260

Company Profile

Development and commercialising molecularly targeted radiation products for the treatment of cancer.

Corporate Website

Financial History

2025A

$-7.1M profit

$803.8M rev

2024A

$33.7M profit

$516.6M rev

2023A

$4.2M profit

$333.0M rev